<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PMC</source><date>20140719</date><key>sentence.key</key><document><id>2275666</id><passage><infon key="name_3">surname:Mizuta;given-names:Shoko</infon><infon key="name_2">surname:Satoh;given-names:Manami</infon><infon key="name_1">surname:Tanaka;given-names:Aki</infon><infon key="article-id_pmid">18354501</infon><infon key="name_0">surname:Okuda;given-names:Masahiko</infon><infon key="fpage">1161</infon><infon key="issue">7</infon><infon key="year">2008</infon><infon key="article-id_pmc">2275666</infon><infon key="alt-title">Mechanism of human TFIIE–TFIIH interaction</infon><infon key="article-id_doi">10.1038/emboj.2008.47</infon><infon key="type">front</infon><infon key="volume">27</infon><infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.</infon><infon key="journal-title">The EMBO Journal</infon><infon key="kwd">complex structure NMR p53 TFIIE TFIIH</infon><infon key="article-id_pii">emboj200847</infon><infon key="lpage">1171</infon><infon key="name_6">surname:Nishimura;given-names:Yoshifumi</infon><infon key="name_5">surname:Ohkuma;given-names:Yoshiaki</infon><infon key="name_4">surname:Takazawa;given-names:Manabu</infon><offset>0</offset><text>Structural insight into the TFIIE–TFIIH interaction: TFIIE and p53 share the binding region on TFIIH</text></passage><passage><infon key="type">abstract</infon><offset>103</offset><text>RNA polymerase II and general transcription factors (GTFs) assemble on a promoter to form a transcription preinitiation complex (PIC). Among the GTFs, TFIIE recruits TFIIH to complete the PIC formation and regulates enzymatic activities of TFIIH. However, the mode of binding between TFIIE and TFIIH is poorly understood. Here, we demonstrate the specific binding of the C-terminal acidic domain (AC-D) of the human TFIIEα subunit to the pleckstrin homology domain (PH-D) of the human TFIIH p62 subunit and describe the solution structures of the free and PH-D-bound forms of AC-D. Although the flexible N-terminal acidic tail from AC-D wraps around PH-D, the core domain of AC-D also interacts with PH-D. AC-D employs an entirely novel binding mode, which differs from the amphipathic helix method used by many transcriptional activators. So the binding surface between PH-D and AC-D is much broader than the specific binding surface between PH-D and the p53 acidic fragments. From our in vitro studies, we demonstrate that this interaction could be a switch to replace p53 with TFIIE on TFIIH in transcription.</text></passage><passage><infon key="type">title_1</infon><offset>1217</offset><text>Introduction</text></passage><passage><infon key="type">paragraph</infon><offset>1230</offset><text>In eukaryotes, transcription of protein-encoding genes is performed by RNA polymerase II (Pol II). Although it is a complex enzyme comprised of 12 subunits, Pol II alone is unable to accurately recognize promoters to initiate transcription. Transcription initiation by Pol II requires five proteins; TFIIB, TFIID, TFIIE, TFIIF and TFIIH collectively known as ‘general transcription factors (GTFs)' (Orphanides et al, 1996; Roeder, 1996). Pol II and GTFs converge on a promoter in a highly ordered manner to form the preinitiation complex (PIC). After the binding of TFIID to the TATA element located 30 nt upstream of the transcription initiation site (+1), TFIIB and TFIIF together with Pol II are recruited. TFIIE then joins the PIC, and finally TFIIE recruits TFIIH. After these steps, double-stranded DNA around the initiation site is melted to the single-stranded form by TFIIH (Dvir et al, 1996). TFIIE binds to the region between −10 and +2 (Douziech et al, 2000), where it is required to initiate melting and assist in the formation of the open complex (Holstege et al, 1996; Okamoto et al, 1998). Following extensive phosphorylation of the C-terminal domain (CTD) of the largest subunit Rpb1 of Pol II by TFIIH, activated Pol II releases all GTFs except for TFIIF and proceeds to transcription elongation (Lu et al, 1992). Upon promoter clearance, TFIIE increases the CTD kinase activity of TFIIH (Drapkin et al, 1994; Ohkuma and Roeder, 1994). Thus, it is now known that both TFIIE and TFIIH have significant functions in transcription initiation and the transition to elongation.</text></passage><passage><infon key="type">paragraph</infon><offset>2825</offset><text>In relation to transcriptional machinery, so far the structures of TBP (TATA box-binding protein) subunit (Nikolov et al, 1992) from TFIID, TBP–DNA (Kim et al, 1993a, 1993b), TBP–DNA–TFIIB (Nikolov et al, 1995), Pol II (Cramer et al, 2000, 2001) and Pol II–TFIIB (Bushnell et al, 2004) have been determined. On the basis of these studies, we can see the detailed structural model for the TBP–DNA–TFIIB–Pol II complex. However, for TFIIF-, TFIIE- and TFIIH-associated complex, only their several domain structures have been determined and their interaction mode has not yet been available. For the structural modelling of the PIC, many structural insights into the interactions among Pol II and GTFs, in particular the interactions between the late entries, TFIIE and TFIIIH, are required.</text></passage><passage><infon key="type">paragraph</infon><offset>3628</offset><text>Human TFIIE (hTFIIE) is a heterodimer, consisting of an α subunit (hTFIIEα, 57 kDa) and a β subunit (hTFIIEβ, 34 kDa) (Ohkuma et al, 1990, 1991; Peterson et al, 1991; Sumimoto et al, 1991; Itoh et al, 2005; Jawhari et al, 2006). Both subunits possess several characteristic sequences and structural/functional domains; for example, a Ser, Thr, Asp and Glu-rich (STDE) sequence and an acidic amino-acid-rich sequence are found in the C-terminal region of hTFIIEα, whereas a Ser-rich sequence is found in the N-terminal region of hTFIIEβ. Furthermore, two tertiary structures of a zinc-finger domain of hTFIIEα (Okuda et al, 2004) and a winged helix/forkhead domain of hTFIIEβ (Okuda et al, 2000) have been solved by NMR spectroscopy.</text><annotation id="0"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="4165" length="195"/><text>Furthermore, two tertiary structures of a zinc-finger domain of hTFIIEα (Okuda et al, 2004) and a winged helix/forkhead domain of hTFIIEβ (Okuda et al, 2000) have been solved by NMR spectroscopy.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>4369</offset><text>Human TFIIH (hTFIIH) is a much larger molecule (480 kDa) consisting of 10 subunits (Giglia-Mari et al, 2004). This is divided into two subcomplexes, a core complex (XPB, p34, p44, p52, p62 and p8/TTDA subunits) and a CDK-activating kinase complex (CAK) (CDK7, cyclin H and MAT1 subunits). The two subcomplexes are linked by the XPD subunit (Schultz et al, 2000). The intriguing feature is that this factor has three enzymatic activities: ATP-dependent DNA helicase, DNA-dependent ATPase and CTD kinase activities, and participates not only in transcription but also in DNA repair and cell cycle control. Of these activities of hTFIIH, hTFIIE stimulates the CTD kinase and ATPase activities, and represses the helicase activity (Lu et al, 1992; Drapkin et al, 1994; Ohkuma and Roeder, 1994).</text></passage><passage><infon key="type">paragraph</infon><offset>5160</offset><text>With regard to the interaction between hTFIIE and hTFIIH, it has been shown that the C-terminal acidic region of hTFIIEα is necessary for native hTFIIH binding (Ohkuma et al, 1995) and hTFIIEα strongly binds to the p62 subunit of hTFIIH (Yamamoto et al, 2001; Okuda et al, 2004). Besides these findings, however, little was known about this fundamental mechanism. Insight into the mechanism is gained from the work described here, which demonstrates that the C-terminal acidic domain (AC-D) of hTFIIEα containing the acidic region specifically binds to the N-terminal pleckstrin homology domain (PH-D) of the p62 subunit of hTFIIH. We have determined structures of both free hTFIIEα AC-D and its form bound to the PH-D of hTFIIH p62 by using NMR spectroscopy. The structures reveal that hTFIIEα AC-D recognizes p62 PH-D tightly through a combination of hydrophobic and electrostatic interactions. hTFIIEα AC-D is found to share its binding surface on p62 PH-D with the acidic transactivation domains (TADs) of tumour supressor protein p53 (Di Lello et al, 2006) and herpes simplex virus protein VP16 (Di Lello et al, 2005). However, hTFIIEα AC-D employs an entirely novel binding mode, which differs from the amphipathic helix method used by many transcriptional activators. Our structural and functional studies are informative with regard to the roles of these proteins in the transcription initiation mechanism.</text><annotation id="1"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="5792" length="127"/><text>We have determined structures of both free hTFIIEα AC-D and its form bound to the PH-D of hTFIIH p62 by using NMR spectroscopy.</text></annotation></passage><passage><infon key="type">title_1</infon><offset>6582</offset><text>Results</text></passage><passage><infon key="type">title_2</infon><offset>6590</offset><text>Structure of hTFIIEα AC-D</text></passage><passage><infon key="type">paragraph</infon><offset>6617</offset><text>It has been reported that the C-terminal acidic region of hTFIIEα is necessary for hTFIIH binding (Figure 1A) (Ohkuma et al, 1995). To characterize the precise interaction at the molecular level, we first solved a solution structure of the AC-D of hTFIIEα using NMR spectroscopy (Figure 1B and Table I). The protein has a globular structure with flexible and disordered tails, consisting of the 16 N-terminal residues (amino acids 378–393) and the 5 C-terminal residues (amino acids 435–439). The core region forms a compact structure; the β-turn (S1–S2) is followed by three α-helices (H1, H2 and H3). These structural elements interact with each other and are maintained by a small but rigid hydrophobic core formed by P394, V396, V398, F403, Y405, V408, L414, V415, M418, E422, K423, Y426, I427, M429 and M433 residues. As the hydrophobic core residues as well as consecutive acidic amino acids found in the N-terminal regions of the AC-Ds are highly conserved in metazoans, they would all be expected to have similar structural features to hTFIIEα AC-D (Figure 1A). The structure seems to be a novel fold; similar structures with a Z score over 2.0 could not be detected by the DALI server.</text><annotation id="2"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="6749" length="171"/><text>To characterize the precise interaction at the molecular level, we first solved a solution structure of the AC-D of hTFIIEα using NMR spectroscopy (Figure 1B and Table I).</text></annotation></passage><passage><infon key="type">title_2</infon><offset>7823</offset><text>hTFIIEα AC-D specifically binds to PH-D of hTFIIH p62</text></passage><passage><infon key="type">paragraph</infon><offset>7878</offset><text>Previous studies showed that hTFIIEα specifically bound to the p62 subunits of hTFIIH (Yamamoto et al, 2001; Okuda et al, 2004). Given that the C-terminal acidic region of hTFIIEα (residues 378–393) is essential for hTFIIH binding (Ohkuma et al, 1995), hTFIIEα AC-D is likely to be responsible for hTFIIH recognition. To confirm this and to identify the AC-D-binding region in p62, we performed a GST pull-down assay using hTFIIEα AC-D and GST-fused p62 deletion mutants (Figure 2A). After purification by glutathione-Sepharose column chromatography, all samples containing the C-terminal region, namely full-length GST–p621−548, GST–p62109−548, GST–p62238−548 and GST–p62333−548, were considerably degraded or incompletely translated (data not shown). Though such instability of the C-terminal half of p62 has previously been reported (Jawhari et al, 2004), we found that full-length GST–p621−548, GST–p621−108, GST–p621−238 and GST–p621−333 bound to hTFIIEα AC-D, whereas no binding was observed with GST–p62109−548, GST–p62238−548, GST–p62333−548 and GST alone (Figure 2B). p62 contains the structurally stable PH-D (residues 1–108) (Gervais et al, 2004) and double BSD domains (residues 109–232) (Doerks et al, 2002) within the N-terminal half. The truncation variants with hTFIIEα-binding ability all possess the PH-D. We therefore asked whether p62 PH-D could interact with full-length hTFIIEα (Figure 2B). The results showed that GST-fused p621−548, p621−108, p621−238 and p621−333, all of which contain N-terminal 108 residues, bound to hTFIIEα, whereas the mutants p62109−548, p62238−548 and p62333−548, which lack those 108 residues, could not bind to hTFIIEα (Figure 2B, lanes 2–5 versus lanes 6–8). Thus, we concluded that hTFIIEα binds specifically to the PH-D of hTFIIH p62 (p62 PH-D) through its AC-D.</text><annotation id="3"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0096</infon><location offset="8196" length="434"/><text>To confirm this and to identify the AC-D-binding region in p62, we performed a GST pull-down assay using hTFIIEα AC-D and GST-fused p62 deletion mutants (Figure 2A). After purification by glutathione-Sepharose column chromatography, all samples containing the C-terminal region, namely full-length GST–p621−548, GST–p62109−548, GST–p62238−548 and GST–p62333−548, were considerably degraded or incompletely translated (data not shown).</text></annotation></passage><passage><infon key="type">title_2</infon><offset>9773</offset><text>Structure of complex between hTFIIEα AC-D and hTFIIH p62 PH-D</text></passage><passage><infon key="type">paragraph</infon><offset>9836</offset><text>To obtain the p62 PH-D-bound structure of hTFIIEα AC-D using NMR, we performed NMR titration experiments in buffers both with and without 100 mM NaCl for both domains (Supplementary Figures 1–3). Although in the 100 mM NaCl buffer the dissociation constant (Kd) between AC-D and p62 PH-D was estimated from the titration plots as 376±81 nM (Supplementary Figure 1C) or 237±82 nM (Supplementary Figure 2C), the NaCl-free buffer NMR titration experiment showed much stronger binding affinity between AC-D and p62 PH-D because of the slow exchange timescale with a Kd below about 150 nM (Supplementary Figure 3). On the basis of these results, we determined the complex structure in 20 mM potassium phosphate buffer without NaCl.</text><annotation id="4"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="9836" length="609"/><text>To obtain the p62 PH-D-bound structure of hTFIIEα AC-D using NMR, we performed NMR titration experiments in buffers both with and without 100 mM NaCl for both domains (Supplementary Figures 1–3). Although in the 100 mM NaCl buffer the dissociation constant (Kd) between AC-D and p62 PH-D was estimated from the titration plots as 376±81 nM (Supplementary Figure 1C) or 237±82 nM (Supplementary Figure 2C), the NaCl-free buffer NMR titration experiment showed much stronger binding affinity between AC-D and p62 PH-D because of the slow exchange timescale with a Kd below about 150 nM (Supplementary Figure 3).</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>10568</offset><text>In total, 4489 NOE-derived distance restraints, including 371 intermolecular NOEs, 120 hydrogen bond restraints and 282 dihedral angle restraints were used to determine the complex structure (Table I). The complex structure is shown in Figure 3A and B. The occluded solvent-accessible surface between hTFIIEα AC-D and p62 PH-D was ∼2300 Å2. The core structure of hTFIIEα AC-D and p62 PH-D in the complex was essentially the same as seen in each isolated free structure except for the extended and highly acidic N-terminal tail of hTFIIEα AC-D. In the free form, it is disordered (Figure 1B) but upon complex formation becomes fixed, forming a new S0 strand that extensively overlays the positively charged surface of p62 PH-D formed by K18, K19, K54, K60, K62 and K93 (Figure 3C). Nine consecutive acidic residues from the N-terminal tail of hTFIIEα AC-D run across the second β-sheet (S5, S6 and S7) of p62 PH-D, electrostatically interacting with K18 and K19 on the loop between the S1 and S2 strands and K60 and K62 on the loop between S5 and S6 strands. The extended tail of hTFIIEα AC-D curves at E386 (Figure 3B). Polypeptides from F387 to A391 of hTFIIEα AC-D align along the S5 strand of p62 PH-D, forming an antiparallel β-sheet structure with it. It is noteworthy that F387 in the sequence of acidic residues is accommodated in a shallow pocket on the second β-sheet of p62 PH-D formed by K54, I55, S56, K60, Q64, L65, Q66 and N76 (Figure 3D). In the pocket, hydrophobic interactions between the aromatic side chain of F387 (hTFIIEα) and the aliphatic portions of K54 and K60 (p62) and amino-aromatic interactions (Burley and Petsko, 1986) between the side chains of F387 and Q64, Q66 and N76 (p62) were observed. E388 (hTFIIEα) interacts through van der Waals contacts with I55 and P57 (p62), and E389 (hTFIIEα) forms a salt bridge with K54 (p62). Similar to as seen for F387 (hTFIIEα), V390 was inserted into a shallow pocket between the S5 strand and the C-terminal H1 helix of p62 PH-D, formed by Q53 and I55 on the S5 strand and K93 and Q97 on the H1 helix (Figure 3E). V390 makes extensive hydrophobic contacts with I55 and the aliphatic regions of Q53, K93 and Q97. The N-terminal tail of hTFIIEα AC-D bends further at D392 (Figure 3B), which causes van der Waals contacts between L100 and P101 (p62) (Figure 3F). D393 (hTFIIEα) at the end of the tail lies in close proximity to Q97 (p62) making van der Waals contact with it.</text></passage><passage><infon key="type">paragraph</infon><offset>13030</offset><text>These interacting amino acids were also observed in the NMR titration experiments. In hTFIIEα AC-D, the NMR signals of E386, F387, E388, E389, V390, A391 and D392 were changed significantly upon addition of p62 PH-D (Supplementary Figure 1B) and also in p62 PH-D the NMR signals of K19, Q53, K54, I55, S56, E58, K60, A61, I63, Q64, L65, Q66, T74, T75 and F77 were changed by adding hTFIIEα AC-D (Supplementary Figure 2B).</text><annotation id="5"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="13030" length="421"/><text>These interacting amino acids were also observed in the NMR titration experiments. In hTFIIEα AC-D, the NMR signals of E386, F387, E388, E389, V390, A391 and D392 were changed significantly upon addition of p62 PH-D (Supplementary Figure 1B) and also in p62 PH-D the NMR signals of K19, Q53, K54, I55, S56, E58, K60, A61, I63, Q64, L65, Q66, T74, T75 and F77 were changed by adding hTFIIEα AC-D (Supplementary Figure 2B).</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>13454</offset><text>It is remarkable that in addition to the interaction involving the N-terminal flexible tail of hTFIIEα AC-D, its core structure also participates in the binding to p62 PH-D (Figure 3F). Several residues in the N- and C-terminal regions of the hTFIIEα AC-D core structure interact with residues located in the C-terminal region of p62 PH-D. P394 (hTFIIEα) at the N terminus of the core structure contributes to the formation of the hydrophobic core of hTFIIEα AC-D and simultaneously makes intimate van der Waals contacts with P101 (p62) and also with the aliphatic portion of Q98 (p62). I395 (hTFIIEα), which is exposed to the surface in the free form, now makes hydrophobic contact with the aliphatic segment of Q98 (p62). R432 (hTFIIEα), which is at the end of the H3 helix, makes van der Waals contacts with P101 and the hydrophobic portion of K102 (p62). M433 (TFIIEα) makes van der Waals contact with the aliphatic region of K104 (p62), which is also able to make an electrostatic interaction with D392 or D436. These interactions allow the core structure of hTFIIEα AC-D to take up a position to the side of p62 PH-D, such that the whole complex structure is well defined as shown in Figure 3A.</text></passage><passage><infon key="type">title_2</infon><offset>14663</offset><text>Effects of hTFIIEα AC-D mutations on binding to p62 PH-D</text></passage><passage><infon key="type">paragraph</infon><offset>14721</offset><text>In functional studies of hTFIIEα, we made several mutants of hTFIIEα by changing S365, V372, D380, E383, F387, V390 and D393 to alanine (S365A, V372A, D380A, E383A, F387A, V390A and D393A) as well as S365E, V372D, F387E and V390K. These mutants were expressed in Escherichia coli with hexa-histidine (6H) at the N terminus. All were soluble and could therefore be easily purified using a Ni-nitrilotriacetic acid (NTA) agarose column (Figure 4A).</text></passage><passage><infon key="type">paragraph</infon><offset>15170</offset><text>The ability of hTFIIEα mutants to bind to GST-tagged p62 PH-D was examined by in vitro binding assay (Figure 4B). The p62 PH-D-binding activity of the hTFIIEα mutants was severely reduced when the AC-D residues, F387 and V390, which fit into shallow pockets of p62 PH-D, were changed to F387A, F387E, V390A and V390K (Figure 4B, second column p62 PH-D, lanes 9–12). We have shown previously that the N terminus of hTFIIEα is essential for binding to hTFIIEβ (Ohkuma et al, 1995). Consistent with these observations is the fact that none of the hTFIIEα mutations affected the binding of hTFIIEα to hTFIIEβ (Figure 4B, third column IIEβ, lanes 3–13).</text></passage><passage><infon key="type">title_2</infon><offset>15831</offset><text>Functional roles of hTFIIEα AC-D during transcription</text></passage><passage><infon key="type">paragraph</infon><offset>15886</offset><text>To further investigate the functional roles of hTFIIEα AC-D, we first checked the effects of the hTFIIEα mutants on basal transcription using the adenovirus major late pML(C2AT)Δ-50 template (Figure 4C). All mutants exhibited defects in transcription. Intriguingly, however, the mutants of S365A, S365E, V372A, V372D, D380A and E383A showed more defects than the p62 PH-D-binding defective mutants (Figure 4C, lanes 3–8 versus lanes 9–13).</text></passage><passage><infon key="type">paragraph</infon><offset>16333</offset><text>We next tested the effects on CTD phosphorylation. Each hTFIIEα mutant was mixed with hTFIIH and Pol II. The mixture was analysed by SDS–PAGE and phosphorylated Rpb1 from Pol II was detected by autoradiography (Figure 4D). All mutants failed to stimulate CTD phosphorylation properly compared with wild type (Figure 4D, lanes 3–13 versus lane 2). Phosphorylation profiles of the above-described mutants (S365A, S365E, V372A, V372D, D380A and E383A) phosphorylated CTD but most of Rpb1 was detected at the hypo-phosphorylated IIa position (Figure 4D, lanes 3–8). In contrast, the p62 PH-D-binding defective mutants phosphorylated CTD only weakly (Figure 4D, lanes 9–12).</text></passage><passage><infon key="type">title_2</infon><offset>17012</offset><text>A part of the hTFIIE-binding surface on hTFIIH p62 is shared with transcriptional activator p53</text></passage><passage><infon key="type">paragraph</infon><offset>17108</offset><text>Recently, the structure of a complex of the PH-D of Saccharomyces cerevisiae Tfb1, a homologue of human p62, with a TAD2 of activator p53 was determined by NMR spectroscopy (Di Lello et al, 2006). The structure of the Tfb1 PH-D closely resembles that of p62, except for its longer connecting loop between S6 and S7 (Figure 5A and B). Furthermore, the herpes simplex virus protein 16 (VP16) TAD also interacts with virtually identical sites of Tfb1 and p62 PH-D (Di Lello et al, 2005). Interestingly, the binding sites of p62 for p53 TAD2 and VP16 TAD significantly overlap with a part of the binding site for hTFIIEα AC-D. However, their binding mode is entirely different. The binding site of p53 TAD2 peptide is disordered in an unbound state, but it forms a nine-residue amphipathic α-helix upon binding to Tfb1 PH-D and p62 PH-D. The p53 helix contacts the second β-sheet of Tfb1 PH-D through the interactions of I50 (p53)—M59, M88 (Tfb1); E51 (p53)—R61 or R86 (Tfb1); W53 (p53)—K57, M59 (Tfb1); F54 (p53)—Q49, A50, T51, M59, L60, R61 (Tfb1); and E56 (p53)—K57 (Tfb1). Although the N-terminal tail of hTFIIEα AC-D also becomes ordered upon binding to p62 PH-D, it forms a bent extended structure containing a S0 strand, but not α-helix. In spite of such great structural differences, both hTFIIEα AC-D and p53 TAD2 peptide insert phenylalanine residues, F387 of hTFIIEα AC-D and F54 of p53 TAD2, into the equivalent pocket on the second β-sheet of p62 PH-D. Although the p53 TAD2 peptide consisting of residues 20–73 forms no contacts beside this limited area, hTFIIEα AC-D further interacts with p62 PH-D as mentioned above. The binding surface area of hTFIIEα AC-D and p62 PH-D is calculated as ∼2300 Å2, which is much larger than the binding area of p53 TAD2 for Tfb1 calculated as ∼800 Å2.</text><annotation id="6"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="17108" length="196"/><text>Recently, the structure of a complex of the PH-D of Saccharomyces cerevisiae Tfb1, a homologue of human p62, with a TAD2 of activator p53 was determined by NMR spectroscopy (Di Lello et al, 2006).</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>18934</offset><text>To analyse this interaction biochemically, several point mutants of p62 PH-D were created, bacterially expressed and used in binding studies with hTFIIEα AC-D and p531−73 (Figure 5C). As controls, AC-D-containing hTFIIEα wild type (IIEα wt) and hTFIIEα351−439 (IIEα351−439) were also examined in parallel. As shown, K54, which forms the shallow pocket for F387 of hTFIIEα AC-D with its side chain interacting electrostatically with E389 of hTFIIEα AC-D, was the residue for which mutation to alanine had the largest effect as it prevented binding of all three hTFIIEα proteins tested (Figure 5C, lane 5). In addition, Q66, which also forms the same shallow pocket for F387 of hTFIIEα AC-D and the side chain of Q66 makes contact with F387 through amino-aromatic interaction, was shown to be essential for binding to hTFIIEα AC-D (Figure 5C, lane 6). The adjacent residues, V68, T74 and N76 of p62 PH-D as well as the N-terminal basic residues, K18 and K19, also affected binding but to a lesser extent (Figure 5C, lanes 3, 4, 7–9). A similar but distinct inhibition profile was observed for the N-terminal TAD of p53 (p531−73). In this case, Q66 was also central to the interaction but the essential binding residues were more widespread (Figure 5C, the bottom column, lanes 3 and 6–9).</text></passage><passage><infon key="type">title_2</infon><offset>20243</offset><text>Replacement of p53 bound to hTFIIH p62 with hTFIIEα</text></passage><passage><infon key="type">paragraph</infon><offset>20296</offset><text>As the overlap of the p62 PH-D-binding region of hTFIIEα AC-D with that of p53 TAD2 was observed and judging from the functional context that p53 may recruit TFIIH at transcriptional activation but at some point TFIIE should take over to recruit TFIIH into the PIC, we then asked whether p53 can be replaced on p62 with hTFIIEα. As shown in Figure 5D, p62 PH-D bound to GST–p53 TAD (p531−73) was removed upon addition of 6H–hTFIIEα wild type (Figure 5D, lanes 2–4). Unbound fractions were then mixed with Ni-NTA resin and FLAG-p62 PH-D bound to 6H–hTFIIEα was detected by western blotting (Figure 5D, lanes 7–9). This clearly demonstrates that p53 binding to p62 can be replaced with hTFIIEα.</text></passage><passage><infon key="type">title_1</infon><offset>21006</offset><text>Discussion</text></passage><passage><infon key="type">title_2</infon><offset>21017</offset><text>Interaction between hTFIIEα AC-D and hTFIIH p62 PH-D and its evolutionary conservation</text></passage><passage><infon key="type">paragraph</infon><offset>21105</offset><text>In the present study, the specific interaction between hTFIIEα AC-D and hTFIIH p62 PH-D was explored, and structures of both the free and PH-D-bound forms of hTFIIEα AC-D were determined. This is the first report of the structural determination of the complex describing the interaction between TFIIE and TFIIH at the molecular level. In the case of hTFIIEα AC-D, its binding site as identified here (residues 378–395) is consistent with the previous report that a deletion mutant of hTFIIEα, Δ377–393 could no longer bind to hTFIIH, whereas a mutant with residues 351–439 could bind (Ohkuma et al, 1995). hTFIIEα possesses another acidic region, the STDE (Ser, Thr, Asp and Glu-rich) region (residues 352–365) immediately before the hTFIIEα AC-D (Figure 1A). To investigate whether the STDE is involved in the binding, we prepared a longer construct (residues 351–439) containing both acidic regions and performed the NMR titration experiment under the same conditions (Supplementary Figure 4). The result was that the NMR signals of STDE showed no significant changes and the Kd of 400±43 nM was almost the same as that estimated using hTFIIEα AC-D. We also examined the binding ability of peptide possessing only an N-terminal tail (AC-D381−394) (Supplementary Figure 5). hTFIIEα AC-D381−394 bound to p62 PH-D with a Kd of 2123±192 nM, which is about ∼6- to 9-fold weaker than that of hTFIIEα AC-D. Although the residues of p62 PH-D whose signals changed significantly were mostly consistent with the binding of AC-D and AC-D381−394, the extents of signal changes in the C-terminal region, to which I395, R432 and M433 of AC-D bind, were reduced. These results clearly indicate that hTFIIEα AC-D, which contains both the core structure and the flexible tail, is necessary and sufficient for the specific binding. This is an entirely new binding mode compared with the canonical binding modes found in some transcriptional activators or repressors, in which an intrinsically disordered region (Dyson and Wright, 2002) of each activation or repression domain binds to a target protein with part of the flexible region forming an ordered structure upon binding to the target. The core structure of hTFIIEα AC-D is essential for its binding to p62 PH-D in addition to its flexible arm.</text><annotation id="7"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="21865" length="391"/><text>To investigate whether the STDE is involved in the binding, we prepared a longer construct (residues 351–439) containing both acidic regions and performed the NMR titration experiment under the same conditions (Supplementary Figure 4). The result was that the NMR signals of STDE showed no significant changes and the Kd of 400±43 nM was almost the same as that estimated using hTFIIEα AC-D.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>23422</offset><text>The binding site of hTFIIH p62 PH-D was localized to the second β-sheet (S5, S6 and S7), the loops between S1 and S2 and between S5 and S6 and the C-terminal H1 helix, where a substantial positive cluster is formed. Therefore, it is reasonable to speculate that the N-terminal highly acidic tail of hTFIIEα AC-D strongly binds to the positively charged surface of hTFIIH p62 PH-D. This is supported by the result that the binding is strengthened by removing NaCl from the buffer in the NMR titration experiments. However, given that the first acidic region, STDE, of hTFIIEα has no effect on the binding, the interaction is not merely based on electrostatic interactions. As seen in the complex structure, the highly conserved F387 and V390 residues in the acidic region of hTFIIEα AC-D, not in the STDE region (Figure 1A) make a large contribution to binding. Thus, the combination of electrostatic and hydrophobic interactions is essential for specific binding.</text><annotation id="8"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="23803" length="131"/><text>This is supported by the result that the binding is strengthened by removing NaCl from the buffer in the NMR titration experiments.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>24390</offset><text>It is interesting that hTFIIEα AC-D partially shares the binding surface of hTFIIH p62 PH-D with acidic transcriptional activators, p53 and VP16 TADs (Di Lello et al, 2005, 2006). As p53 and VP16 TADs are able to bind to the PH-Ds of both p62 and Tfb1, their interactions are likely to be evolutionally conserved. For yeast TFIIEα (Tfa1), functional significance of the C-terminal region and specific interaction between Tfa1 and Tfb1 has been reported (Bushnell et al, 1996; Kuldell and Buratowski, 1997). We aligned sequences of TFIIEα AC-D from other species to ascertain whether the interaction observed in human is evolutionally conserved (Figure 1A). As described above, the residues forming the hydrophobic core are well conserved in metazoans, but not in yeast, S. cerevisiae and Schizosaccharomyces pombe. Thus, yeast homologues are unlikely to have a similar core structure to that of human AC-D. However, in yeast similar sequences to the binding site are found in the equivalent positions. Furthermore, in contrast to metazoans, only fungal homologues possess the third acidic region at the C termini. Surprisingly, similar sequences to the binding site are found in the third acidic regions of both S. cerevisiae and S. pombe. Considering that the main binding site of hTFIIEα AC-D is located on the N-terminal tail outside the core structure, Tfa1 does not seem to have a similar core AC-D structure, but the interaction with PH-D is likely to be conserved. This suggests that the interplay between hTFIIEα AC-D, hTFIIH p62 PH-D and p53 TAD2 (and VP16 TAD as well) is evolutionally conserved.</text></passage><passage><infon key="type">title_2</infon><offset>26002</offset><text>Functional roles of hTFIIEα AC-D</text></passage><passage><infon key="type">paragraph</infon><offset>26036</offset><text>In hTFIIEα AC-D, F387 and V390 are the centre of the p62 PH-D-binding region (Figure 4B). As expected, the p62 PH-D-binding defective mutants (F387A, F387E, V390A and V390K) showed defects in in vitro transcription (20–40% reduction from the wild type, Figure 4C, lane 2 versus lanes 9–12). The reason why transcription did not correlate well with the binding and CTD phosphorylation defects might be because there are more than 25 proteins involved in transcription, whereas only limited factors were used for both binding and phosphorylation studies (hTFIIEα AC-D mutants and p62 PH-D were used for binding studies and hTFIIEα AC-D mutants, hTFIIH and Pol II were used for CTD phosphorylation). As a result, other GTFs will be able to support the recruitment of hTFIIH to the correct position in the PIC even in the absence of hTFIIEα AC-D. In addition, bigger defects were observed for mutations of the STDE and in the N-terminal half of hTFIIEα AC-D (S365, V372, D380 and E383) (Figure 4C, lanes 3–8). This effect maybe a result of the action of GTFs with the possibility that this region of hTFIIEα exerts an effect as a binding site for one or more of the general factors. We will test this possibility in the immediate future.</text></passage><passage><infon key="type">title_2</infon><offset>27282</offset><text>Functional implication of the interplay between TFIIE, TFIIH and acidic transcriptional activators</text></passage><passage><infon key="type">paragraph</infon><offset>27381</offset><text>In many cases, acidic TADs are disordered in an unbound form, but form an amphipathic helix upon binding to target proteins, for example, p53 TAD2–RPA70 (replication protein A 70) (Bochkareva et al, 2005), p53 TAD1–MDM2 (ubiquitin ligase) (Kussie et al, 1996), VP16 TAD–hTAFII31 (human TBP-associated factor) (Uesugi et al, 1997) complexes as well as the recently determined Tfb1 PH-D–p53 TAD2 complex (Di Lello et al, 2006). In contrast, hTFIIEα AC-D uniquely binds to p62 PH-D through its core structure together with its flexible N-terminal tail. The Kd values for the binding of p53 TAD2 to p62 and Tfb1 PH-Ds determined by isothermal titration calorimetry (ITC) are 3175±570 and 391±74 nM, respectively (Di Lello et al, 2006). In the binding of VP16 TAD to Tfb1 PH-D, the Kd value estimated by NMR titration experiment was ∼4000–7000 nM (Di Lello et al, 2005). Compared with these Kd values, the binding of hTFIIEα AC-D to p62 PH-D is rather strong. One of the well-known functions of transcriptional activators is to promote transcription initiation by increasing recruitment efficiency of Pol II and GTFs (Ptashne and Gann, 1997). TFIIH is recruited through many activator-mediated routes. p62 has been shown to interact with the TADs of not only VP16 and p53 (Xiao et al, 1994) but also E2F-1 (Pearson and Greenblatt, 1997), and the oestrogen receptor α (ERα) (Chen et al, 2000). Of these, it was demonstrated that p53, VP16 and ERα target p62 PH-D. The notable finding from the present study is that hTFIIEα also targets p62 PH-D (Figure 2). To our knowledge, this is the first GTF demonstrated to possess a functional TAD-like motif. As shown in Figure 5D, hTFIIEα could replace p53 TAD and then bind to p62 PH-D. It can be imagined that if TFIIH is recruited by an activator near the promoter through its TAD then the recruited TFIIH could be captured by TFIIE instead of the activator to form the PIC. TFIIE regulates the enzymatic activities of TFIIH, which are necessary for the next stage after the PIC formation, that is, promoter melting or promoter clearance. In contrast, activators cannot directly participate in these processes. Efficient delivery of p62 from activators to TFIIEα is considered to be essential for the final recruitment of TFIIH to form the PIC in vivo. The replacement observed in Figure 5D could be related to this final recruitment. We show in Figure 5A–C that p53 (Di Lello et al, 2006) and VP16 (Di Lello et al, 2005) use part of the binding surface formed between p62 PH-D and hTFIIEα AC-D. The use of an overlapping binding surface on p62 PH-D with p53 TAD2 may be advantageous in the delivery of TFIIH from activators to TFIIE.</text><annotation id="9"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0065</infon><location offset="27931" length="181"/><text>The Kd values for the binding of p53 TAD2 to p62 and Tfb1 PH-Ds determined by isothermal titration calorimetry (ITC) are 3175±570 and 391±74 nM, respectively (Di Lello et al, 2006).</text></annotation><annotation id="10"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="28113" length="133"/><text>In the binding of VP16 TAD to Tfb1 PH-D, the Kd value estimated by NMR titration experiment was ∼4000–7000 nM (Di Lello et al, 2005).</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>30080</offset><text>The binding affinity of p53 TAD2 to p62 PH-D is regulated by S46 and T55 phosphorylation (Di Lello et al, 2006). The Kd values of p53 TAD2 to p62 PH-D are reported for the unphosphorylated form as 3175±570 nM, for the S46-phosphorylated form as 518±92 nM, for the T55-phosphorylated form as 457±75 nM and for both S46- and T55-phosphorylated form as 97±33 nM. Very recent ITC studies demonstrated the Kd value of hTFIIEα336−439 to p62 PH-D to be 45±25 nM (Di Lello et al, 2008). Intriguingly, the binding affinity of hTFIIEα336−439 to p62 PH-D is much stronger than unphosphorylated p53 TAD2 and is comparable to doubly phosphorylated TAD2. As both TFIIH and p53 function not only in transcription but also in DNA repair (Kastan et al, 1991; Drapkin et al, 1994) and p62 PH-D is involved in nucleotide excision repair (Gervais et al, 2004), p62 may serve as a molecular switch between transcription and DNA repair. We imagine that when p53 TAD2 is unphosphorylated, the delivery of p62 from p53 TAD2 to hTFIIEα would be efficient and they would function cooperatively in transcription initiation. However, when p53 TAD2 is doubly phosphorylated at S46 and T55, the affinity of p53 TAD2 for p62 PH-D would be comparable to that for hTFIIEα resulting in p53 and p62 (hTFIIH) functioning in DNA repair or in processes other than transactivation. Further studies are required to verify these possibilities.</text><annotation id="11"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0065</infon><location offset="30440" length="118"/><text>Very recent ITC studies demonstrated the Kd value of hTFIIEα336−439 to p62 PH-D to be 45±25 nM (Di Lello et al, 2008).</text></annotation></passage><passage><infon key="type">title_1</infon><offset>31496</offset><text>Materials and methods</text></passage><passage><infon key="type">title_2</infon><offset>31518</offset><text>Construction of mutants of hTFIIEα and hTFIIH p62 subunits</text></passage><passage><infon key="type">paragraph</infon><offset>31578</offset><text>By using the Multi Site-Directed Mutagenesis Kit (Medical Biology Laboratory) as a template with wild-type hTFIIEα cDNA plasmid or a hTFIIH p62 cDNA mutant in which a NdeI site was disrupted by changing the third nucleotide of the 45th histidine codon of wild-type hTFIIH p62 cDNA, T to C, various oligonucleotide-mediated point mutants were created (Kunkel et al, 1987). The mutants were checked by sequencing using an ABI Prism 310 Genetic Analyzer (Applied Biosystems). The oligonucleotides used for mutation are listed in Supplementary Table I. The NdeI–BamHI fragment of mutated hTFIIEα cDNA was subcloned into the pET11d vector (Novagen) making the N-terminal hexa histidine-tagged hTFIIEα (6H–hTFIIEα) expression plasmid. The NdeI–BamHI fragment of mutated hTFIIH p62 cDNA was subcloned into the pET vector making the N-terminal FLAG-tagged hTFIIH p62 PH-D (FLAG–p62 PH) expression plasmid.</text></passage><passage><infon key="type">title_2</infon><offset>32488</offset><text>Purification of hTFIIEα AC-D and hTFIIH p62 PH-D</text></passage><passage><infon key="type">paragraph</infon><offset>32538</offset><text>hTFIIEα AC-D (residues 378–439) was expressed as an hexa histidine-tagged product in pET3a vectors (Novagen) in E. coli BL21(DE3)pLysS (Novagen). Lysed supernatant was loaded onto the Ni-NTA-agarose (Qiagen) column. The eluate was then applied onto Q-Sepharose (GE Healthcare). After digestion with thrombin to remove the 6H tag, sample was again loaded onto the Ni-NTA agarose column. Fractions passing through the column were concentrated and applied onto Superdex30 (GE Healthcare). hTFIIH p62 PH-D was purified as described (Gervais et al, 2004).</text><annotation id="12"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0004</infon><location offset="32816" length="107"/><text>After digestion with thrombin to remove the 6H tag, sample was again loaded onto the Ni-NTA agarose column.</text></annotation></passage><passage><infon key="type">title_2</infon><offset>33092</offset><text>NMR spectroscopy</text></passage><passage><infon key="type">paragraph</infon><offset>33109</offset><text>Measurements of NMR spectra, structural calculations and NMR titration experiments are described in Supplementary data.</text></passage><passage><infon key="type">title_2</infon><offset>33229</offset><text>Purification of recombinant proteins</text></passage><passage><infon key="type">paragraph</infon><offset>33266</offset><text>Recombinant point mutant hTFIIEα proteins were expressed in E. coli Rosetta™(DE3)pLysS (Novagen), and recombinant hTFIIH p62 point mutants were expressed in BL21(DE3)pLysS by induction with isopropyl-β-D-thiogalactopyranoside (Studier et al, 1990). The purification method of these recombinant proteins was as described previously (Watanabe et al, 2003). Typical preparations were >90% pure, judging by Coomassie blue staining of an SDS–polyacrylamide gel.</text><annotation id="13"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0276</infon><location offset="33621" length="101"/><text>Typical preparations were >90% pure, judging by Coomassie blue staining of an SDS–polyacrylamide gel.</text></annotation></passage><passage><infon key="type">title_2</infon><offset>33729</offset><text>GST pull-down assay</text></passage><passage><infon key="type">paragraph</infon><offset>33749</offset><text>GST fusion proteins were used for protein interaction assays (Okamoto et al, 1998). The bound proteins were released by boiling in SDS–PAGE loading buffer, separated by SDS–PAGE and detected by western blotting with anti-hTFIIEα rabbit antiserum (1:3000 dilution), anti-FLAG M2 monoclonal antibody (Sigma) and anti-p53 (DO-1) (Santa Cruz) using the enhanced chemiluminescence detection system (GE Healthcare).</text><annotation id="14"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0019</infon><location offset="33833" length="325"/><text>The bound proteins were released by boiling in SDS–PAGE loading buffer, separated by SDS–PAGE and detected by western blotting with anti-hTFIIEα rabbit antiserum (1:3000 dilution), anti-FLAG M2 monoclonal antibody (Sigma) and anti-p53 (DO-1) (Santa Cruz) using the enhanced chemiluminescence detection system (GE Healthcare).</text></annotation></passage><passage><infon key="type">title_2</infon><offset>34164</offset><text>In vitro transcription assay</text></passage><passage><infon key="type">paragraph</infon><offset>34193</offset><text>Recombinant GTFs as well as native Pol II and hTFIIH were purified as described previously (Watanabe et al, 2003). In vitro transcription was performed as described (Ohkuma et al, 1995). The plasmid pML(C2AT)Δ-50 containing the adenovirus 2 major late promoter, which gives a 390-nt transcript, was used as either a supercoiled or a linearized template for basal transcription assays (Yamamoto et al, 2001). To prepare the linearized template, pML(C2AT)Δ-50 was digested with SmaI. After transcription, radiolabeled transcripts were subjected to urea–PAGE and detected by autoradiography. The transcripts were quantified by a Fuji BAS5000 Bio-Imaging Analyzer. Relative transcription activities of the mutant hTFIIEα proteins were calculated by defining the transcription activity of the wild-type hTFIIEα as 100%.</text></passage><passage><infon key="type">title_2</infon><offset>35014</offset><text>Kinase assay</text></passage><passage><infon key="type">paragraph</infon><offset>35027</offset><text>In addition to transcription factors added as described in the legend of Figure 4D, the kinase reaction mixture (25 μl) contained 5 mM HEPES-KOH (pH 7.8), 20 mM Tris–HCl (pH 7.9 at 4°C), 7 mM MgCl2, 60 mM KCl, 12% (v/v) glycerol, 2% (w/v) polyethylene glycol 8000, 2 mM 2-mercaptoethanol, 0.1 mM EDTA, 240 μg/ml of bovine serum albumin, 5 μM ATP and 3 μCi of [γ-32P]ATP. Phosphorylation reactions were carried out at 30°C for 1 h and stopped by addition of 75 μl of phosphorylation stop solution (10 mM EDTA, 0.1% NP40 and 0.05% SDS). Phosphorylated proteins were precipitated with TCA, analysed by SDS–PAGE (5.5% acrylamide), and detected by autoradiography with Fuji RX-U X-ray film.</text></passage><passage><infon key="type">title_2</infon><offset>35725</offset><text>Accession numbers</text></passage><passage><infon key="type">paragraph</infon><offset>35743</offset><text>Coordinates of hTFIIEα AC-D free and in complex with hTFIIH p62 PH-D have been deposited in the Protein Data Bank (www.rcsb.org) under accession codes 2RNQ and 2RNR, respectively.</text></passage><passage><infon key="type">title_1</infon><offset>35924</offset><text>Supplementary Material</text></passage><passage><infon key="name_3">surname:Yi;given-names:GS</infon><infon key="name_2">surname:Ayed;given-names:A</infon><infon key="name_1">surname:Kaustov;given-names:L</infon><infon key="name_0">surname:Bochkareva;given-names:E</infon><infon key="fpage">15412</infon><infon key="pub-id_pmid">16234232</infon><infon key="citation">, , , , , , , , , ,  () .  : –</infon><infon key="year">2005</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="name_10">surname:Bochkarev;given-names:A</infon><infon key="name_9">surname:Arrowsmith;given-names:CH</infon><infon key="name_8">surname:Milner;given-names:J</infon><infon key="name_7">surname:Okorokov;given-names:AL</infon><infon key="lpage">15417</infon><infon key="name_6">surname:Liao;given-names:JC</infon><infon key="name_5">surname:Pineda-Lucena;given-names:A</infon><infon key="name_4">surname:Lu;given-names:Y</infon><offset>35947</offset><text>Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A</text></passage><passage><infon key="volume">203</infon><infon key="name_1">surname:Petsko;given-names:GA</infon><infon key="name_0">surname:Burley;given-names:SK</infon><infon key="fpage">139</infon><infon key="pub-id_pmid">3089835</infon><infon key="citation">,  () .  : –</infon><infon key="year">1986</infon><infon key="source">FEBS Lett</infon><infon key="type">ref</infon><infon key="lpage">143</infon><offset>36048</offset><text>Amino-aromatic interactions in proteins</text></passage><passage><infon key="volume">271</infon><infon key="name_2">surname:Kornberg;given-names:RD</infon><infon key="name_1">surname:Bamdad;given-names:C</infon><infon key="name_0">surname:Bushnell;given-names:DA</infon><infon key="fpage">20170</infon><infon key="pub-id_pmid">8702741</infon><infon key="citation">, ,  () .  : –</infon><infon key="year">1996</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="lpage">20174</infon><offset>36088</offset><text>A minimal set of RNA polymerase II transcription protein interactions</text></passage><passage><infon key="name_3">surname:Kornberg;given-names:RD</infon><infon key="volume">303</infon><infon key="name_2">surname:Davis;given-names:RE</infon><infon key="name_1">surname:Westover;given-names:KD</infon><infon key="name_0">surname:Bushnell;given-names:DA</infon><infon key="fpage">983</infon><infon key="pub-id_pmid">14963322</infon><infon key="citation">, , ,  () .  : –</infon><infon key="year">2004</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="lpage">988</infon><offset>36158</offset><text>Structural basis of transcription: an RNA polymerase II–TFIIB cocrystal at 4.5 Angstroms</text></passage><passage><infon key="name_3">surname:Pace;given-names:PE</infon><infon key="name_2">surname:Washbrook;given-names:E</infon><infon key="name_1">surname:Riedl;given-names:T</infon><infon key="name_0">surname:Chen;given-names:D</infon><infon key="fpage">127</infon><infon key="pub-id_pmid">10949034</infon><infon key="citation">, , , , , ,  () .  : –</infon><infon key="year">2000</infon><infon key="source">Mol Cell</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="lpage">137</infon><infon key="name_6">surname:Ali;given-names:S</infon><infon key="name_5">surname:Egly;given-names:JM</infon><infon key="name_4">surname:Coombes;given-names:RC</infon><offset>36249</offset><text>Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7</text></passage><passage><infon key="name_3">surname:Gnatt;given-names:AL</infon><infon key="name_2">surname:Fu;given-names:J</infon><infon key="name_1">surname:Bushnell;given-names:DA</infon><infon key="name_0">surname:Cramer;given-names:P</infon><infon key="fpage">640</infon><infon key="pub-id_pmid">10784442</infon><infon key="citation">, , , , , , , , ,  () .  : –</infon><infon key="year">2000</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">288</infon><infon key="name_9">surname:Kornberg;given-names:RD</infon><infon key="name_8">surname:David;given-names:PR</infon><infon key="name_7">surname:Edwards;given-names:AM</infon><infon key="lpage">649</infon><infon key="name_6">surname:Burgess;given-names:RR</infon><infon key="name_5">surname:Thompson;given-names:NE</infon><infon key="name_4">surname:Maier-Davis;given-names:B</infon><offset>36388</offset><text>Architecture of RNA polymerase II and implications for the transcription mechanism</text></passage><passage><infon key="volume">292</infon><infon key="name_2">surname:Kornberg;given-names:RD</infon><infon key="name_1">surname:Bushnell;given-names:DA</infon><infon key="name_0">surname:Cramer;given-names:P</infon><infon key="fpage">1863</infon><infon key="pub-id_pmid">11313498</infon><infon key="citation">, ,  () .  : –</infon><infon key="year">2001</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="lpage">1876</infon><offset>36471</offset><text>Structural basis of transcription: RNA polymerase II at 2.8 Angstrom resolution</text></passage><passage><infon key="name_3">surname:Nguyen;given-names:BD</infon><infon key="name_2">surname:Jones;given-names:TN</infon><infon key="name_1">surname:Miller Jenkins;given-names:LM</infon><infon key="name_0">surname:Di Lello;given-names:P</infon><infon key="fpage">731</infon><infon key="pub-id_pmid">16793543</infon><infon key="citation">, , , , , , , , ,  () .  : –</infon><infon key="year">2006</infon><infon key="source">Mol Cell</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="name_9">surname:Omichinski;given-names:JG</infon><infon key="name_8">surname:Legault;given-names:P</infon><infon key="name_7">surname:Appella;given-names:E</infon><infon key="lpage">740</infon><infon key="name_6">surname:Dikeakos;given-names:JD</infon><infon key="name_5">surname:Yamaguchi;given-names:H</infon><infon key="name_4">surname:Hara;given-names:T</infon><offset>36551</offset><text>Structure of the Tfb1/p53 complex: insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53</text></passage><passage><infon key="name_3">surname:Langlois;given-names:C</infon><infon key="name_2">surname:Mas;given-names:C</infon><infon key="name_1">surname:Miller Jenkins;given-names:LM</infon><infon key="name_0">surname:Di Lello;given-names:P</infon><infon key="fpage">106</infon><infon key="pub-id_pmid">18160537</infon><infon key="citation">, , , , , , , ,  () .  : –</infon><infon key="year">2008</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="volume">105</infon><infon key="name_8">surname:Omichinski;given-names:JG</infon><infon key="name_7">surname:Legault;given-names:P</infon><infon key="lpage">111</infon><infon key="name_6">surname:Archambault;given-names:J</infon><infon key="name_5">surname:Fradet-Turcotte;given-names:A</infon><infon key="name_4">surname:Malitskaya;given-names:E</infon><offset>36687</offset><text>p53 and TFIIEα share a common binding site on the Tfb1/p62 subunit of TFIIH</text></passage><passage><infon key="name_3">surname:Potempa;given-names:K</infon><infon key="name_2">surname:Jones;given-names:TN</infon><infon key="name_1">surname:Nguyen;given-names:BD</infon><infon key="name_0">surname:Di Lello;given-names:P</infon><infon key="fpage">7678</infon><infon key="pub-id_pmid">15909982</infon><infon key="citation">, , , , , ,  () .  : –</infon><infon key="year">2005</infon><infon key="source">Biochemistry</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="lpage">7686</infon><infon key="name_6">surname:Omichinski;given-names:JG</infon><infon key="name_5">surname:Legault;given-names:P</infon><infon key="name_4">surname:Kobor;given-names:MS</infon><offset>36764</offset><text>NMR structure of the amino-terminal domain from the Tfb1 subunit of TFIIH and characterization of its phosphoinositide and VP16 binding sites</text></passage><passage><infon key="name_3">surname:Bork;given-names:P</infon><infon key="volume">27</infon><infon key="name_2">surname:Buchner;given-names:E</infon><infon key="name_1">surname:Huber;given-names:S</infon><infon key="name_0">surname:Doerks;given-names:T</infon><infon key="fpage">168</infon><infon key="pub-id_pmid">11943536</infon><infon key="citation">, , ,  () .  : –</infon><infon key="year">2002</infon><infon key="source">Trends Biochem Sci</infon><infon key="type">ref</infon><infon key="lpage">170</infon><offset>36906</offset><text>BSD: a novel domain in transcription factors and synapse-associated proteins</text></passage><passage><infon key="name_3">surname:Arai;given-names:Y</infon><infon key="name_2">surname:Chipoulet;given-names:JM</infon><infon key="name_1">surname:Coin;given-names:F</infon><infon key="name_0">surname:Douziech;given-names:M</infon><infon key="fpage">8168</infon><infon key="pub-id_pmid">11027286</infon><infon key="citation">, , , , , ,  () .  : –</infon><infon key="year">2000</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="lpage">8177</infon><infon key="name_6">surname:Coulombe;given-names:B</infon><infon key="name_5">surname:Egly;given-names:J-M</infon><infon key="name_4">surname:Ohkuma;given-names:Y</infon><offset>36983</offset><text>Mechanism of promoter melting by the xeroderma pigmentosum complementation group B helicase of transcription factor IIH revealed by protein–DNA photo-crosslinking</text></passage><passage><infon key="name_3">surname:Huang;given-names:JC</infon><infon key="name_2">surname:Ansari;given-names:A</infon><infon key="name_1">surname:Reardon;given-names:JT</infon><infon key="name_0">surname:Drapkin;given-names:R</infon><infon key="fpage">769</infon><infon key="pub-id_pmid">8152490</infon><infon key="citation">, , , , , , ,  () .  : –</infon><infon key="year">1994</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">368</infon><infon key="name_7">surname:Reinberg;given-names:D</infon><infon key="lpage">772</infon><infon key="name_6">surname:Sancar;given-names:A</infon><infon key="name_5">surname:Ahn;given-names:K</infon><infon key="name_4">surname:Zawel;given-names:L</infon><offset>37148</offset><text>Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II</text></passage><passage><infon key="name_3">surname:Egly;given-names:J-M</infon><infon key="name_2">surname:Chalut;given-names:C</infon><infon key="name_1">surname:Garrett;given-names:KP</infon><infon key="name_0">surname:Dvir;given-names:A</infon><infon key="fpage">7245</infon><infon key="pub-id_pmid">8631733</infon><infon key="citation">, , , , ,  () .  : –</infon><infon key="year">1996</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">271</infon><infon key="lpage">7248</infon><infon key="name_5">surname:Conaway;given-names:RC</infon><infon key="name_4">surname:Conaway;given-names:JW</infon><offset>37232</offset><text>A role for ATP and TFIIH in activation of the RNA polymerase II preinitiation complex prior to transcription initiation</text></passage><passage><infon key="volume">12</infon><infon key="name_1">surname:Wright;given-names:PE</infon><infon key="name_0">surname:Dyson;given-names:HJ</infon><infon key="fpage">54</infon><infon key="pub-id_pmid">11839490</infon><infon key="citation">,  () .  : –</infon><infon key="year">2002</infon><infon key="source">Curr Opin Struct Biol</infon><infon key="type">ref</infon><infon key="lpage">60</infon><offset>37352</offset><text>Coupling of folding and binding for unstructured proteins</text></passage><passage><infon key="name_3">surname:Frindel;given-names:F</infon><infon key="name_2">surname:Jawhari;given-names:A</infon><infon key="name_1">surname:Lamour;given-names:V</infon><infon key="name_0">surname:Gervais;given-names:V</infon><infon key="fpage">616</infon><infon key="pub-id_pmid">15195146</infon><infon key="citation">, , , , , , , , ,  () .  : –</infon><infon key="year">2004</infon><infon key="source">Nat Struct Mol Biol</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="name_9">surname:Poterszman;given-names:A</infon><infon key="name_8">surname:Kieffer;given-names:B</infon><infon key="name_7">surname:Thierry;given-names:JC</infon><infon key="lpage">622</infon><infon key="name_6">surname:Egly;given-names:JM</infon><infon key="name_5">surname:Dubaele;given-names:S</infon><infon key="name_4">surname:Wasielewski;given-names:E</infon><offset>37410</offset><text>TFIIH contains a PH domain involved in DNA nucleotide excision repair</text></passage><passage><infon key="name_3">surname:Hoogstraten;given-names:D</infon><infon key="name_2">surname:Ranish;given-names:JA</infon><infon key="name_1">surname:Coin;given-names:F</infon><infon key="name_0">surname:Giglia-Mari;given-names:G</infon><infon key="fpage">714</infon><infon key="pub-id_pmid">15220921</infon><infon key="citation">, , , , , , , , , , , , , , ,  () .  : –</infon><infon key="year">2004</infon><infon key="source">Nat Genet</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="name_10">surname:Botta;given-names:E</infon><infon key="name_13">surname:Aebersold;given-names:R</infon><infon key="name_14">surname:Hoeijmakers;given-names:JH</infon><infon key="name_11">surname:Stefanini;given-names:M</infon><infon key="name_12">surname:Egly;given-names:JM</infon><infon key="name_15">surname:Vermeulen;given-names:W</infon><infon key="name_9">surname:van der Spek;given-names:PJ</infon><infon key="name_8">surname:Argentini;given-names:M</infon><infon key="name_7">surname:Raams;given-names:A</infon><infon key="lpage">719</infon><infon key="name_6">surname:Jaspers;given-names:NG</infon><infon key="name_5">surname:Wijgers;given-names:N</infon><infon key="name_4">surname:Theil;given-names:A</infon><offset>37480</offset><text>A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A</text></passage><passage><infon key="volume">15</infon><infon key="name_2">surname:Timmers;given-names:HTM</infon><infon key="name_1">surname:van der Vliet;given-names:PC</infon><infon key="name_0">surname:Holstege;given-names:FCP</infon><infon key="fpage">1666</infon><infon key="pub-id_pmid">8612591</infon><infon key="citation">, ,  () .  : –</infon><infon key="year">1996</infon><infon key="source">EMBO J</infon><infon key="type">ref</infon><infon key="lpage">1677</infon><offset>37581</offset><text>Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH</text></passage><passage><infon key="name_3">surname:Nagadoi;given-names:A</infon><infon key="name_2">surname:Sato;given-names:M</infon><infon key="name_1">surname:Unzai;given-names:S</infon><infon key="name_0">surname:Itoh;given-names:Y</infon><infon key="fpage">633</infon><infon key="pub-id_pmid">16184598</infon><infon key="citation">, , , , , ,  () .  : –</infon><infon key="year">2005</infon><infon key="source">Proteins</infon><infon key="type">ref</infon><infon key="volume">61</infon><infon key="lpage">641</infon><infon key="name_6">surname:Akashi;given-names:S</infon><infon key="name_5">surname:Nishimura;given-names:Y</infon><infon key="name_4">surname:Okuda;given-names:M</infon><offset>37708</offset><text>Investigation of molecular size of transcription factor TFIIE in solution</text></passage><passage><infon key="name_3">surname:Atkinson;given-names:RA</infon><infon key="name_2">surname:Lamour;given-names:V</infon><infon key="name_1">surname:Boussert;given-names:S</infon><infon key="name_0">surname:Jawhari;given-names:A</infon><infon key="fpage">14420</infon><infon key="pub-id_pmid">15533047</infon><infon key="citation">, , , , , , , , ,  () .  : –</infon><infon key="year">2004</infon><infon key="source">Biochemistry</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="name_9">surname:Poterszman;given-names:A</infon><infon key="name_8">surname:Moras;given-names:D</infon><infon key="name_7">surname:van Dorsselaer;given-names:A</infon><infon key="lpage">14430</infon><infon key="name_6">surname:Potier;given-names:N</infon><infon key="name_5">surname:Poch;given-names:O</infon><infon key="name_4">surname:Kieffer;given-names:B</infon><offset>37782</offset><text>Domain architecture of the p62 subunit from the human transcription/repair factor TFIIH deduced by limited proteolysis and mass spectrometry analysis</text></passage><passage><infon key="name_3">surname:Crucifix;given-names:C</infon><infon key="name_2">surname:De Carlo;given-names:S</infon><infon key="name_1">surname:Uhring;given-names:M</infon><infon key="name_0">surname:Jawhari;given-names:A</infon><infon key="fpage">500</infon><infon key="pub-id_pmid">16547462</infon><infon key="citation">, , , , , , ,  () .  : –</infon><infon key="year">2006</infon><infon key="source">EMBO Rep</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="name_7">surname:Poterszman;given-names:A</infon><infon key="lpage">505</infon><infon key="name_6">surname:Schultz;given-names:P</infon><infon key="name_5">surname:Moras;given-names:D</infon><infon key="name_4">surname:Tocchini-Valentini;given-names:G</infon><offset>37932</offset><text>Structure and oligomeric state of human transcription factor TFIIE</text></passage><passage><infon key="name_3">surname:Vogelstein;given-names:B</infon><infon key="name_2">surname:Sidransky;given-names:D</infon><infon key="name_1">surname:Onyekwere;given-names:O</infon><infon key="name_0">surname:Kastan;given-names:MB</infon><infon key="fpage">6304</infon><infon key="pub-id_pmid">1933891</infon><infon key="citation">, , , ,  () .  : –</infon><infon key="year">1991</infon><infon key="source">Cancer Res</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="lpage">6311</infon><infon key="name_4">surname:Craig;given-names:RW</infon><offset>37999</offset><text>Participation of p53 protein in the cellular response to DNA damage</text></passage><passage><infon key="volume">365</infon><infon key="name_2">surname:Burley;given-names:SK</infon><infon key="name_1">surname:Nikolov;given-names:DB</infon><infon key="name_0">surname:Kim;given-names:JL</infon><infon key="fpage">520</infon><infon key="pub-id_pmid">8413605</infon><infon key="citation">, ,  () .  : –</infon><infon key="year">1993a</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="lpage">527</infon><offset>38067</offset><text>Co-crystal structure of TBP recognizing the minor groove of a TATA element</text></passage><passage><infon key="name_3">surname:Sigler;given-names:PB</infon><infon key="volume">365</infon><infon key="name_2">surname:Hahn;given-names:S</infon><infon key="name_1">surname:Geiger;given-names:JH</infon><infon key="name_0">surname:Kim;given-names:Y</infon><infon key="fpage">512</infon><infon key="pub-id_pmid">8413604</infon><infon key="citation">, , ,  () .  : –</infon><infon key="year">1993b</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="lpage">520</infon><offset>38142</offset><text>Crystal structure of a yeast TBP/TATA-box complex</text></passage><passage><infon key="volume">17</infon><infon key="name_1">surname:Buratowski;given-names:S</infon><infon key="name_0">surname:Kuldell;given-names:NH</infon><infon key="fpage">5288</infon><infon key="pub-id_pmid">9271406</infon><infon key="citation">,  () .  : –</infon><infon key="year">1997</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="lpage">5298</infon><offset>38192</offset><text>Genetic analysis of the large subunit of yeast transcription factor IIE reveals two regions with distinct functions</text></passage><passage><infon key="volume">154</infon><infon key="name_2">surname:Zakour;given-names:RA</infon><infon key="name_1">surname:Roberts;given-names:JD</infon><infon key="name_0">surname:Kunkel;given-names:TA</infon><infon key="fpage">367</infon><infon key="pub-id_pmid">3323813</infon><infon key="citation">, ,  () .  : –</infon><infon key="year">1987</infon><infon key="source">Methods Enzymol</infon><infon key="type">ref</infon><infon key="lpage">382</infon><offset>38308</offset><text>Rapid and efficient site-specific mutagenesis without phenotypic selections</text></passage><passage><infon key="name_3">surname:Elenbaas;given-names:B</infon><infon key="name_2">surname:Marechal;given-names:V</infon><infon key="name_1">surname:Gorina;given-names:S</infon><infon key="name_0">surname:Kussie;given-names:PH</infon><infon key="fpage">948</infon><infon key="pub-id_pmid">8875929</infon><infon key="citation">, , , , , ,  () .  : –</infon><infon key="year">1996</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">274</infon><infon key="lpage">953</infon><infon key="name_6">surname:Pavletich;given-names:NP</infon><infon key="name_5">surname:Levine;given-names:AJ</infon><infon key="name_4">surname:Moreau;given-names:J</infon><offset>38384</offset><text>Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</text></passage><passage><infon key="name_3">surname:Egly;given-names:J-M</infon><infon key="name_2">surname:Fisher;given-names:L</infon><infon key="name_1">surname:Zawel;given-names:L</infon><infon key="name_0">surname:Lu;given-names:H</infon><infon key="fpage">641</infon><infon key="pub-id_pmid">1495560</infon><infon key="citation">, , , ,  () .  : –</infon><infon key="year">1992</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">358</infon><infon key="lpage">645</infon><infon key="name_4">surname:Reinberg;given-names:D</infon><offset>38475</offset><text>Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II</text></passage><passage><infon key="name_3">surname:Usheva;given-names:AA</infon><infon key="name_2">surname:Halay;given-names:ED</infon><infon key="name_1">surname:Chen;given-names:H</infon><infon key="name_0">surname:Nikolov;given-names:DB</infon><infon key="fpage">119</infon><infon key="pub-id_pmid">7675079</infon><infon key="citation">, , , , , , ,  () .  : –</infon><infon key="year">1995</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">377</infon><infon key="name_7">surname:Burley;given-names:SK</infon><infon key="lpage">128</infon><infon key="name_6">surname:Roeder;given-names:RG</infon><infon key="name_5">surname:Lee;given-names:DK</infon><infon key="name_4">surname:Hisatake;given-names:K</infon><offset>38572</offset><text>Crystal structure of a TFIIB–TBP–TATA-element ternary complex</text></passage><passage><infon key="name_3">surname:Gasch;given-names:A</infon><infon key="name_2">surname:Lin;given-names:J</infon><infon key="name_1">surname:Hu;given-names:SH</infon><infon key="name_0">surname:Nikolov;given-names:DB</infon><infon key="fpage">40</infon><infon key="pub-id_pmid">1436073</infon><infon key="citation">, , , , , , , ,  () .  : –</infon><infon key="year">1992</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">360</infon><infon key="name_8">surname:Burley;given-names:SK</infon><infon key="name_7">surname:Roeder;given-names:RG</infon><infon key="lpage">46</infon><infon key="name_6">surname:Chua;given-names:NH</infon><infon key="name_5">surname:Horikoshi;given-names:M</infon><infon key="name_4">surname:Hoffmann;given-names:A</infon><offset>38638</offset><text>Crystal structure of TFIID TATA-box binding protein</text></passage><passage><infon key="name_3">surname:Horikoshi;given-names:M</infon><infon key="name_2">surname:Wang;given-names:CK</infon><infon key="name_1">surname:Hashimoto;given-names:S</infon><infon key="name_0">surname:Ohkuma;given-names:Y</infon><infon key="fpage">4856</infon><infon key="pub-id_pmid">7651404</infon><infon key="citation">, , , ,  () .  : –</infon><infon key="year">1995</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="lpage">4866</infon><infon key="name_4">surname:Roeder;given-names:RG</infon><offset>38690</offset><text>Analysis of the role of TFIIE in basal transcription and TFIIH-mediated carboxy-terminal domain phosphorylation through structure–function studies of TFIIE-α</text></passage><passage><infon key="volume">368</infon><infon key="name_1">surname:Roeder;given-names:RG</infon><infon key="name_0">surname:Ohkuma;given-names:Y</infon><infon key="fpage">160</infon><infon key="pub-id_pmid">8166891</infon><infon key="citation">,  () .  : –</infon><infon key="year">1994</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="lpage">163</infon><offset>38851</offset><text>Regulation of TFIIH ATPase and kinase activities by TFIIE during active initiation complex formation</text></passage><passage><infon key="name_3">surname:Shimasaki;given-names:S</infon><infon key="name_2">surname:Hoffmann;given-names:A</infon><infon key="name_1">surname:Sumimoto;given-names:H</infon><infon key="name_0">surname:Ohkuma;given-names:Y</infon><infon key="fpage">398</infon><infon key="pub-id_pmid">1956403</infon><infon key="citation">, , , , ,  () .  : –</infon><infon key="year">1991</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">354</infon><infon key="lpage">401</infon><infon key="name_5">surname:Roeder;given-names:RG</infon><infon key="name_4">surname:Horikoshi;given-names:M</infon><offset>38952</offset><text>Structural motifs and potential σ homologies in the large subunit of human general transcription factor TFIIE</text></passage><passage><infon key="name_3">surname:Roeder;given-names:RG</infon><infon key="volume">87</infon><infon key="name_2">surname:Horikoshi;given-names:M</infon><infon key="name_1">surname:Sumimoto;given-names:H</infon><infon key="name_0">surname:Ohkuma;given-names:Y</infon><infon key="fpage">9163</infon><infon key="pub-id_pmid">2251258</infon><infon key="citation">, , ,  () .  : –</infon><infon key="year">1990</infon><infon key="source">Proc Natl Acad Sci USA</infon><infon key="type">ref</infon><infon key="lpage">9167</infon><offset>39063</offset><text>Factors involved in specific transcription by mammalian RNA polymerase II: purification and characterization of general transcription factor TFIIE</text></passage><passage><infon key="name_3">surname:Ohta;given-names:T</infon><infon key="name_2">surname:Watanabe;given-names:Y</infon><infon key="name_1">surname:Yamamoto;given-names:S</infon><infon key="name_0">surname:Okamoto;given-names:T</infon><infon key="fpage">19866</infon><infon key="pub-id_pmid">9677423</infon><infon key="citation">, , , , , ,  () .  : –</infon><infon key="year">1998</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">273</infon><infon key="lpage">19876</infon><infon key="name_6">surname:Ohkuma;given-names:Y</infon><infon key="name_5">surname:Roeder;given-names:RG</infon><infon key="name_4">surname:Hanaoka;given-names:F</infon><offset>39210</offset><text>Analysis of the role of TFIIE in transcriptional regulation through structure–function studies of the TFIIEβ subunit</text></passage><passage><infon key="name_3">surname:Satoh;given-names:M</infon><infon key="name_2">surname:Arai;given-names:Y</infon><infon key="name_1">surname:Tanaka;given-names:A</infon><infon key="name_0">surname:Okuda;given-names:M</infon><infon key="fpage">51395</infon><infon key="pub-id_pmid">15385556</infon><infon key="citation">, , , , , , , ,  () .  : –</infon><infon key="year">2004</infon><infon key="source">J Biol Chem</infon><infon key="type">ref</infon><infon key="volume">279</infon><infon key="name_8">surname:Nishimura;given-names:Y</infon><infon key="name_7">surname:Ohkuma;given-names:Y</infon><infon key="lpage">51403</infon><infon key="name_6">surname:Hanaoka;given-names:F</infon><infon key="name_5">surname:Nagadoi;given-names:A</infon><infon key="name_4">surname:Okamura;given-names:H</infon><offset>39330</offset><text>A novel zinc finger structure in the large subunit of human general transcription factor TFIIE</text></passage><passage><infon key="name_3">surname:Hanaoka;given-names:F</infon><infon key="name_2">surname:Okamura;given-names:H</infon><infon key="name_1">surname:Watanabe;given-names:Y</infon><infon key="name_0">surname:Okuda;given-names:M</infon><infon key="fpage">1346</infon><infon key="pub-id_pmid">10716934</infon><infon key="citation">, , , , ,  () .  : –</infon><infon key="year">2000</infon><infon key="source">EMBO J</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="lpage">1356</infon><infon key="name_5">surname:Nishimura;given-names:Y</infon><infon key="name_4">surname:Ohkuma;given-names:Y</infon><offset>39425</offset><text>Structure of the central core domain of TFIIEβ with a novel double-stranded DNA-binding</text></passage><passage><infon key="volume">10</infon><infon key="name_2">surname:Reinberg;given-names:D</infon><infon key="name_1">surname:Lagrange;given-names:T</infon><infon key="name_0">surname:Orphanides;given-names:G</infon><infon key="fpage">2657</infon><infon key="pub-id_pmid">8946909</infon><infon key="citation">, ,  () .  : –</infon><infon key="year">1996</infon><infon key="source">Genes Dev</infon><infon key="type">ref</infon><infon key="lpage">2683</infon><offset>39514</offset><text>The general transcription factors of RNA polymerase II</text></passage><passage><infon key="volume">15</infon><infon key="name_1">surname:Greenblatt;given-names:J</infon><infon key="name_0">surname:Pearson;given-names:A</infon><infon key="fpage">2643</infon><infon key="pub-id_pmid">9400991</infon><infon key="citation">,  () .  : –</infon><infon key="year">1997</infon><infon key="source">Oncogene</infon><infon key="type">ref</infon><infon key="lpage">2658</infon><offset>39569</offset><text>Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH</text></passage><passage><infon key="name_3">surname:Flores;given-names:O</infon><infon key="name_2">surname:Maxon;given-names:ME</infon><infon key="name_1">surname:Inostroza;given-names:J</infon><infon key="name_0">surname:Peterson;given-names:MG</infon><infon key="fpage">369</infon><infon key="pub-id_pmid">1956398</infon><infon key="citation">, , , , , ,  () .  : –</infon><infon key="year">1991</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">354</infon><infon key="lpage">373</infon><infon key="name_6">surname:Tjian;given-names:R</infon><infon key="name_5">surname:Reinberg;given-names:D</infon><infon key="name_4">surname:Admon;given-names:A</infon><offset>39689</offset><text>Structure and functional properties of human general transcription factor IIE</text></passage><passage><infon key="volume">386</infon><infon key="name_1">surname:Gann;given-names:A</infon><infon key="name_0">surname:Ptashne;given-names:M</infon><infon key="fpage">569</infon><infon key="pub-id_pmid">9121580</infon><infon key="citation">,  () .  : –</infon><infon key="year">1997</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="lpage">577</infon><offset>39767</offset><text>Transcriptional activation by recruitment</text></passage><passage><infon key="volume">21</infon><infon key="name_0">surname:Roeder;given-names:RG</infon><infon key="fpage">327</infon><infon key="pub-id_pmid">8870495</infon><infon key="citation"> () .  : –</infon><infon key="year">1996</infon><infon key="source">Trends Biochem Sci</infon><infon key="type">ref</infon><infon key="lpage">335</infon><offset>39809</offset><text>The role of general initiation factors in transcription by RNA polymerase II</text></passage><passage><infon key="name_3">surname:Mallouh;given-names:V</infon><infon key="name_2">surname:Poterszman;given-names:A</infon><infon key="name_1">surname:Fribourg;given-names:S</infon><infon key="name_0">surname:Schultz;given-names:P</infon><infon key="fpage">599</infon><infon key="pub-id_pmid">11007478</infon><infon key="citation">, , , , ,  () .  : –</infon><infon key="year">2000</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">102</infon><infon key="lpage">607</infon><infon key="name_5">surname:Egly;given-names:JM</infon><infon key="name_4">surname:Moras;given-names:D</infon><offset>39886</offset><text>Molecular structure of human TFIIH</text></passage><passage><infon key="name_3">surname:Dubendorff;given-names:JW</infon><infon key="volume">185</infon><infon key="name_2">surname:Dunn;given-names:JJ</infon><infon key="name_1">surname:Rosenberg;given-names:AH</infon><infon key="name_0">surname:Studier;given-names:FW</infon><infon key="fpage">60</infon><infon key="pub-id_pmid">2199796</infon><infon key="citation">, , ,  () .  : –</infon><infon key="year">1990</infon><infon key="source">Methods Enzymol</infon><infon key="type">ref</infon><infon key="lpage">89</infon><offset>39921</offset><text>Use of T7 RNA polymerase to direct expression of cloned genes</text></passage><passage><infon key="name_3">surname:Kato;given-names:H</infon><infon key="name_2">surname:Sinn;given-names:E</infon><infon key="name_1">surname:Ohkuma;given-names:Y</infon><infon key="name_0">surname:Sumimoto;given-names:H</infon><infon key="fpage">401</infon><infon key="pub-id_pmid">1956404</infon><infon key="citation">, , , , , ,  () .  : –</infon><infon key="year">1991</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">354</infon><infon key="lpage">404</infon><infon key="name_6">surname:Roeder;given-names:RG</infon><infon key="name_5">surname:Horikoshi;given-names:M</infon><infon key="name_4">surname:Shimasaki;given-names:S</infon><offset>39983</offset><text>Conserved sequence motifs in the small subunit of human general transcription factor TFIIE</text></passage><passage><infon key="name_3">surname:Levine;given-names:AJ</infon><infon key="name_2">surname:Lu;given-names:H</infon><infon key="name_1">surname:Nyanguile;given-names:O</infon><infon key="name_0">surname:Uesugi;given-names:M</infon><infon key="fpage">1310</infon><infon key="pub-id_pmid">9271577</infon><infon key="citation">, , , ,  () .  : –</infon><infon key="year">1997</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">277</infon><infon key="lpage">1313</infon><infon key="name_4">surname:Verdine;given-names:GL</infon><offset>40074</offset><text>Induced alpha helix in the VP16 activation domain upon binding to a human TAF</text></passage><passage><infon key="name_3">surname:Furumoto;given-names:T</infon><infon key="name_2">surname:Tanaka;given-names:A</infon><infon key="name_1">surname:Hayashi;given-names:K</infon><infon key="name_0">surname:Watanabe;given-names:T</infon><infon key="fpage">2914</infon><infon key="pub-id_pmid">12665589</infon><infon key="citation">, , , , ,  () .  : –</infon><infon key="year">2003</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="lpage">2926</infon><infon key="name_5">surname:Ohkuma;given-names:Y</infon><infon key="name_4">surname:Hanaoka;given-names:F</infon><offset>40152</offset><text>The carboxy terminus of the small subunit of TFIIE regulates the transition from transcription initiation to elongation by RNA polymerase II</text></passage><passage><infon key="name_3">surname:Truant;given-names:R</infon><infon key="name_2">surname:Coulombe;given-names:B</infon><infon key="name_1">surname:Pearson;given-names:A</infon><infon key="name_0">surname:Xiao;given-names:H</infon><infon key="fpage">7013</infon><infon key="pub-id_pmid">7935417</infon><infon key="citation">, , , , , , , , , ,  () .  : –</infon><infon key="year">1994</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="name_10">surname:Greenblatt;given-names:J</infon><infon key="name_9">surname:Ingles;given-names:CJ</infon><infon key="name_8">surname:Flores;given-names:O</infon><infon key="name_7">surname:Reinberg;given-names:D</infon><infon key="lpage">7024</infon><infon key="name_6">surname:Triezenberg;given-names:SJ</infon><infon key="name_5">surname:Regier;given-names:JL</infon><infon key="name_4">surname:Zhang;given-names:S</infon><offset>40293</offset><text>Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53</text></passage><passage><infon key="name_3">surname:Watanabe;given-names:T</infon><infon key="name_2">surname:van der Spek;given-names:PJ</infon><infon key="name_1">surname:Watanabe;given-names:Y</infon><infon key="name_0">surname:Yamamoto;given-names:S</infon><infon key="fpage">1</infon><infon key="pub-id_pmid">11113176</infon><infon key="citation">, , , , , ,  () .  : –</infon><infon key="year">2001</infon><infon key="source">Mol Cell Biol</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="lpage">15</infon><infon key="name_6">surname:Ohkuma;given-names:Y</infon><infon key="name_5">surname:Hanaoka;given-names:F</infon><infon key="name_4">surname:Fujimoto;given-names:H</infon><offset>40386</offset><text>Studies of nematode TFIIE function reveal a link between Ser-5 phosphorylation of RNA polymerase II and the transition from transcription initiation to elongation</text></passage><passage><infon key="type">fig_caption</infon><offset>40549</offset><text>The C-terminal acidic domain (AC-D) of hTFIIEα. (A) Sequence alignment of hTFIIEα AC-D and its homologues. H, human; M, mouse; X, Xenopus laevis; D, Drosophila melanogaster; C, Caenorhabditis elegans; Sp, Schizosaccharomyces pombe; Sc, Saccharomyces cerevisiae. Acidic amino acids, D and E are coloured in red. Conserved residues are shown in bold. The p62 PH-D-binding site of hTFIIEα and similar sequences are underlined. Secondary structures of hTFIIEα AC-D are depicted above human sequence. Arrows and cylinders represent β-strands and α-helices, respectively. Orange circles indicate residues participating in the formation of the hydrophobic core. Yellow circles indicate mutation sites. (B) Solution structure of hTFIIEα AC-D. Left, superposition of the backbone heavy atoms of the 20 lowest energy NMR structures. Right, ribbon representation of the average structure.</text></passage><passage><infon key="type">fig_caption</infon><offset>41434</offset><text>The pleckstrin homology domain (PH-D) of the p62 subunit of hTFIIH directly binds to hTFIIEα AC-D. (A) Schematic drawing of GST fusion hTFIIH p62 deletion mutants. (B) GST pull-down assay of hTFIIEα AC-D with wild type and p62 mutants. Lane 1, GST; lane 2, GST–p62 (1–548aa); lane 3, GST–p62 (1–108aa); lane 4, GST–p62 (1–238aa); lane 5, GST–p62 (1–333aa); lane 6, GST–p62 (109–548aa); lane 7, GST–p62 (238–548aa); lane 8, GST–p62 (333–548aa); lane 9, 20% input. Arrowheads on the left side indicate band position of hTFIIEα AC-D and wild type (hTFIIEα wt) as indicated. Bound proteins were detected by western blotting with anti-hTFIIEα antisera (anti-IIEα) (lower panel). The p62 PH-D deletion mutants are indicated on the top of the panel.</text><annotation id="15"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0096</infon><location offset="41598" length="71"/><text>(B) GST pull-down assay of hTFIIEα AC-D with wild type and p62 mutants.</text></annotation></passage><passage><infon key="type">fig_caption</infon><offset>42211</offset><text>Structure of complex of hTFIIEα AC-D and hTFIIH p62 PH-D. (A) Superposition of the backbone heavy atoms of the 20 lowest energy NMR structures. Structures are superimposed over residues 383–433 of hTFIIEα AC-D shown in green, and residues 7–104 of p62 PH-D shown in orange (left), residues 393–433 of TFIIEα AC-D (middle) and residues 7–104 of p62 PH-D (right), respectively. (B) Ribbon representation of the average structure. (C) Electrostatic interaction. Positive and negative potentials on the molecular surface are coloured in blue and red, respectively. (D) Binding pocket of p62 PH-D for F387 of hTFIIEα AC-D. (E) Binding pocket of p62 PH-D for V390 of hTFIIEα AC-D. In (C–E), hTFIIEα AC-D is represented as a stick model, and p62 PH-D is shown as a molecular surface. (F) Interface between the core structure of hTFIIEα AC-D and p62 PH-D. Residues that participate in the binding are shown with the side chains.</text><annotation id="16"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0077</infon><location offset="42269" length="85"/><text>(A) Superposition of the backbone heavy atoms of the 20 lowest energy NMR structures.</text></annotation></passage><passage><infon key="type">fig_caption</infon><offset>43149</offset><text>Binding surfaces between hTFIIEα AC-D and p62 PH-D are essential for transcription and CTD phosphorylation. (A) SDS–PAGE of the hTFIIEα mutants. In total, 400 ng of each purified hTFIIEα protein was subjected to SDS–PAGE (10% acrylamide) and stained with Coomassie blue. Lane 1, wild-type hTFIIEα; lanes 2–12, point mutants. The sizes of the molecular weight markers are indicated on the right (in kDa). Mutated residues are indicated at the top of each lane. (B) Effect of point mutations of hTFIIEα on p62 PH-D binding. The top panel shows 5% input of hTFIIEα mutant proteins (IIEα mutants). hTFIIEα proteins bound to the GST-tagged p62 PH-D and hTFIIEβ were separated by SDS–PAGE and detected by western blotting with anti-hTFIIEα antisera. Lane 1, no hTFIIEα (−IIEα); lane 2, hTFIIEα wild type (IIEα wt); lanes 3–13, point mutant proteins. Mutated residues are indicated at the top of each lane. (C) Effects of hTFIIEα AC-D point mutations on the basal transcription activity. Relative transcription activities (bars) of the mutant hTFIIEα proteins with a linearized template are presented by defining the transcription activity of wild-type hTFIIEα as 100%. Mutated residues are indicated at the top of each panel. As a control, transcription was performed without hTFIIEα (−IIEα). An arrow (right side of panel) indicates the position of the 390-nt transcripts. (D) Effects of hTFIIEα AC-D point mutations on hTFIIH-mediated CTD phosphorylation. The kinase assay was performed with Pol II, hTFIIH, hTFIIEα and hTFIIEα mutants in the absence of DNA. Lane 1, no hTFIIEα (−IIEα); lane 2, wild-type hTFIIEα (IIEα wt); lanes 3–13, point mutants. The mutated residues are indicated at the top of each lane. Arrows indicate the phosphorylated form (IIo) and the unphosphorylated form (IIa) of the largest subunit Rpb1 of Pol II.</text></passage><passage><infon key="type">fig_caption</infon><offset>45021</offset><text>hTFIIEα AC-D shares the p62 PH-D-binding surface with p53 TAD. (A) Structure of hTFIIEα AC-D–hTFIIH p62 PH-D complex. (B) Structure of p53 TAD2–Tfb1 PH-D complex (PDB ID; 2GS0). Interacting residues are indicated with the side chains and interaction areas are roughly marked in yellow. Residues that form the binding pockets for F387 of hTFIIEα AC-D and for F54 of p53 TAD2 are labelled. In (B), the residues of Tfb1 that are important in the interaction with F54 of p53 TAD2 are marked together with the corresponding residues of p62. (C) Effect of p62 PH-D point mutations on binding to the acidic region of hTFIIEα and p53. The top panel shows 5 ng of FLAG-tagged p62 PH-D mutant proteins (p62 PH-D mutants). p62 PH-D mutants were mixed with GST–hTFIIEα wild type (IIEα wt), GST–hTFIIEα351−439 (IIEα351−439), GST–hTFIIEα AC-D (IIEα AC-D) or GST–p531−73 (p531−73) bound to the glutathione-Sepharose resin. Bound mutants were subjected to SDS–PAGE and detected by western blotting with anti-FLAG antibody. Lane 1, no p62 PH-D (−p62 PH-D); lane 2, wild-type p62 PH-D (p62 PH-D wt); lanes 3–9, p62 PH-D point mutants. Mutated residues are indicated at the top of each lane. (D) Competition of p53 TAD binding to p62 PH-D with hTFIIEα. FLAG-tagged p62 PH-D was mixed with GST–p531−73 (p531−73). For competition study, 6H–hTFIIEα wild type was added to the mixture bound to glutathione-Sepharose (glut-Seph) resin. Unbound material was then added to Ni-NTA agarose. Bound proteins were subjected to SDS–PAGE and detected by western blotting with anti-FLAG, anti-p53 and anti-hTFIIEα antisera.</text><annotation id="17"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0019</infon><location offset="45929" length="98"/><text>Bound mutants were subjected to SDS–PAGE and detected by western blotting with anti-FLAG antibody.</text></annotation><annotation id="18"><infon key="type">ExperimentalMethod</infon><infon key="PSIMI">0019</infon><location offset="46484" length="126"/><text>Bound proteins were subjected to SDS–PAGE and detected by western blotting with anti-FLAG, anti-p53 and anti-hTFIIEα antisera.</text></annotation></passage><passage><infon key="type">table_caption</infon><offset>46660</offset><text>Structural statistics for the 20 best structures of hTFIIEα AC-D and its complex with hTFIIH p62 PH-D</text></passage><passage><infon key="type">table</infon><offset>46763</offset><text>     Free Complex    hTFIIEα AC-D Htfiieα AC-D   hTFIIH p62 PH-D   Experimental restraints           Total distance restraints 1205 1296   2822    Intraresidue 101 145   287    Sequential (i–j=1) 372 372   701    Medium-range (1&lt;i–j&lt;5) 367 391   536    Intramolecular long range (i–j⩾5) 333 344   1222    Intermolecular     371      Hydrogen bond 16 × 2 22 × 2   38 × 2   Number of dihedral restraints            ϕ 35 35   65    Ψ 32 35   64    χ1 21 25   46    χ2 1 2   10             Statistics for structure calculations           r.m.s. deviations from experimental restraintsa            Distance (Å) 0.010±0.000   0.014±0.000      Dihedral (deg) 0.080±0.026   0.47±0.03     r.m.s. deviations from idealized covalent geometry            Bonds (Å) 0.0020±0.0001   0.0020±0.0000      Angles (deg) 0.53±0.00   0.55±0.00      Improper (deg) 0.40±0.01   0.44±0.01     Final energies            E total (kcal mol−1) 100.5±0.6   347.8±4.2      E bond (kcal mol−1) 3.3±0.3   11.1±0.4      E angle (kcal mol−1) 75.3±0.6   230.4±1.9      E van der Waals (kcal mol−1) 3.1±0.4   20.6±1.7      E NOE (kcal mol−1) 6.5±0.5   41.5±2.8      E dihedral (kcal mol−1) 0.0±0.0   3.6±0.5      E improper (kcal mol−1) 12.4±0.6   40.6±1.1     Coordinate precision            Backbone atoms (Å) 0.24±0.08b 0.20±0.04b 0.44±0.08c 0.58±0.11d    Heavy atoms (Å) 0.70±0.07b 0.68±0.05b 0.85±0.10c 0.95±0.10d   Ramachandran plot statistics            Most favoured regions (%) 82.9b   79.4d      Additional allowed regions (%) 17.1b   16.9d      Generously allowed regions (%) 0.0b   2.9d      Disallowed regions (%) 0.0b   0.7d    aNone of the structures exhibited distance violations >0.5 Å, dihedral angle violations >5°.  bThe value was calculated over residues 393–433 of hTFIIEα AC-D of the free form or in the complex.  cThe value was calculated over residues 7–104 of hTFIIH p62 PH-D in the complex.  dThe value was calculated over residues 383–433 of hTFIIEα AC-D and residues 7–104 of hTFIIH p62 PH-D in the complex.</text></passage></document></collection>